Genetic architecture of host proteins involved in SARS-CoV-2 infection
Finding effective treatments for COVID-19 depends upon understanding genetic regulation of proteins involved in SARS-CoV-2 infection and host response. Here, the authors identify genetic variants linked to expression of such proteins, data which could lead to the discovery of therapeutic targets.
Guardado en:
Autores principales: | Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, Johannes Raffler, Nicola D. Kerrison, Erin Oerton, Victoria P. W. Auyeung, Jian’an Luan, Chris Finan, Juan P. Casas, Rachel Ostroff, Steve A. Williams, Gabi Kastenmüller, Markus Ralser, Eric R. Gamazon, Nicholas J. Wareham, Aroon D. Hingorani, Claudia Langenberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b38e315ccef41ffb7a303ba54fecf8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic insights into human health from aptamer- and antibody-based proteomic profiling
por: Maik Pietzner, et al.
Publicado: (2021) -
GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health
por: Yajie Zhao, et al.
Publicado: (2021) -
Sex-specific metabolic profiles of androgens and its main binding protein SHBG in a middle aged population without diabetes
por: Uwe Piontek, et al.
Publicado: (2017) -
Mapping the serum proteome to neurological diseases using whole genome sequencing
por: Grace Png, et al.
Publicado: (2021) -
Genetic drug target validation using Mendelian randomisation
por: Amand F. Schmidt, et al.
Publicado: (2020)